Ligand profile
QU4
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00801 — Uracil-DNA glycosylase
Identifiers
Database identifiers and provenance.
- Ligand ID
QU4- PDB
6vba- UniProt (similar protein)
P13051- Target protein
- KP13_00801
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 169.4
- −1 ≤ LogP ≤ 5 2.45
- MW ≤ 500 Da 422.3
- LogP ≤ 5 2.45
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 169.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(c(cc1C(=C2C=CC(=O)C(=C2)C(=O)O)c3ccc(c(c3)C(=O)O)O)C(=O)O)Oc1cc(c(cc1C(=C2C=CC(=O)C(=C2)C(=O)O)c3ccc(c(c3)C(=O)O)O)C(=O)O)O
InChI=1S/C22H14O9/c23-16-4-1-10(7-13(16)20(26)27)19(11-2-5-17(24)14(8-11)21(28)29)12-3-6-18(25)15(9-12)22(30)31/h1-9,23-24H,(H,26,27)(H,28,29)(H,30,31)InChI=1S/C22H14O9/c23-16-4-1-10(7-13(16)20(26)27)19(11-2-5-17(24)14(8-11)21(28)29)12-3-6-18(25)15(9-12)22(30)31/h1-9,23-24H,(H,26,27)(H,28,29)(H,30,31)
GIXWDMTZECRIJT-UHFFFAOYSA-NGIXWDMTZECRIJT-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF03167
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand QU4 →
- PDB RCSB structure 6vba →
- UniProt UniProt P13051 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “QU4”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00801.
PDB 15
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).